LENACAPAVIR vs LENIOLISIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LENACAPAVIR vs LENIOLISIB: Safety Overview
| Metric | LENACAPAVIR | LENIOLISIB |
|---|---|---|
| Total FAERS Reports | 502 | 570 |
| Deaths Reported | 32 | 6 |
| Death Rate | 6.4% | 1.1% |
| Hospitalizations | 42 | 54 |
| Average Patient Age | 50.0 yrs | 19.4 yrs |
| % Female Patients | 24.7% | 27.3% |
| FDA Approval Date | Dec 22, 2022 | Mar 24, 2023 |
| Manufacturer | Gilead Sciences, Inc. | Pharming Healthcare Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |